'Female sperm' and 'male eggs' may be possible

Image
Press Trust of India London
Last Updated : Aug 23 2013 | 3:56 PM IST
Researchers have suggested that it may be possible in the future to create sperm from women and eggs from men - a feat, that if achieved, could revolutionise infertility treatments.
Katsuhiko Hayashi of Kyoto University in Japan and his senior professor Mitinori Saitou used skin cells from mice to create primordial germ cells or PGCs. PGCs are the common precursor of both male and female sex cells.
These cells were then developed into both sperm and eggs. Scientists used these to create live-births via in vitro fertilisation.
The technique offers numerous possibilities for reproductive medicine. It may allow infertile women to have babies by creating eggs from their skin cells, and also make it possible for sperm and eggs cells to be created from either males or females, 'The Independent' reported.
In the technique, pluripotent stem cells were extracted from early-stage embryos and somatic cells, and were then converted into PGCs using signalling molecules.
These germ cells were transplanted into the ovaries and testes of living mice to develop. Once these cells were mature they were extracted and used to fertilise one another in vitro.
The initial research took place in October last year, with researchers claiming that the live-births were merely a 'side effect' of the research to demonstrate that the creation of PGCs had been successful.
Other researchers have replicated the production of PGCs but could not succeed in producing live births. The scientists involved also have many other hurdles to overcome including the production of 'fragile' and 'misshapen' eggs, wrote David Cyranoski in 'Scientific American'.
The Japanese team is now working on monkey embryos and believe they could repeat the mouse work in monkeys within 5-10 years, with the creation of human PGCs following shortly after.
While making PGCs for infertility treatment will be a huge jump, many scientists are urging caution as embryonic stem cells frequently pick up chromosomal abnormalities, genetic mutations and epigenetic irregularities during culture.
Hayashi has also said that a viable infertility treatment could be 10 or even 50 years in the future.
"My impression is that it is very far away. I don't want to give people unfeasible hope," he said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 23 2013 | 3:56 PM IST

Next Story